BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 12652615)

  • 1. Treatment of Ewing sarcoma family of tumors: current status and outlook for the future.
    Rodriguez-Galindo C; Spunt SL; Pappo AS
    Med Pediatr Oncol; 2003 May; 40(5):276-87. PubMed ID: 12652615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment approaches for metastatic Ewing's sarcoma: a review of the literature.
    Hendershot E
    J Pediatr Oncol Nurs; 2005; 22(6):339-52. PubMed ID: 16216896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose chemotherapy and stem cell rescue for high-risk Ewing's family of tumors.
    Rosenthal J; Pawlowska AB
    Expert Rev Anticancer Ther; 2011 Feb; 11(2):251-62. PubMed ID: 21342043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival after recurrence of Ewing's sarcoma family of tumors.
    Barker LM; Pendergrass TW; Sanders JE; Hawkins DS
    J Clin Oncol; 2005 Jul; 23(19):4354-62. PubMed ID: 15781881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of prognostic factors in ewing sarcoma family of tumors: review of St. Jude Children's Research Hospital studies.
    Rodríguez-Galindo C; Liu T; Krasin MJ; Wu J; Billups CA; Daw NC; Spunt SL; Rao BN; Santana VM; Navid F
    Cancer; 2007 Jul; 110(2):375-84. PubMed ID: 17569105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment results of the Ewing sarcoma of bone and prognostic factors.
    Sari N; Toğral G; Cetindağ MF; Güngör BS; Ilhan IE
    Pediatr Blood Cancer; 2010 Jan; 54(1):19-24. PubMed ID: 19760772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High histologic and overall response to dose intensification of ifosfamide, carboplatin, and etoposide with cyclophosphamide, doxorubicin, and vincristine in patients with high-risk Ewing sarcoma family tumors: the Bambino Gesù Children's Hospital experience.
    Milano GM; Cozza R; Ilari I; De Sio L; Boldrini R; Jenkner A; De Ioris M; Inserra A; Dominici C; Donfrancesco A
    Cancer; 2006 Apr; 106(8):1838-45. PubMed ID: 16532434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose therapy with hematopoietic stem cell rescue in patients with poor prognosis Ewing family tumors.
    Rosenthal J; Bolotin E; Shakhnovits M; Pawlowska A; Falk P; Qian D; Oliver C; Sato J; Miser J; Forman S
    Bone Marrow Transplant; 2008 Sep; 42(5):311-8. PubMed ID: 18587438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Definitive surgery and multiagent systemic therapy for patients with localized Ewing sarcoma family of tumors: local outcome and prognostic factors.
    Krasin MJ; Davidoff AM; Rodriguez-Galindo C; Billups CA; Fuller CE; Neel MD; Merchant TE
    Cancer; 2005 Jul; 104(2):367-73. PubMed ID: 15948159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current treatment for Ewing's sarcoma.
    Thacker MM; Temple HT; Scully SP
    Expert Rev Anticancer Ther; 2005 Apr; 5(2):319-31. PubMed ID: 15877528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ewing's sarcoma family of tumors: an overview from diagnosis to survivorship.
    Lahl M; Fisher VL; Laschinger K
    Clin J Oncol Nurs; 2008 Feb; 12(1):89-97. PubMed ID: 18258578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ewing sarcoma].
    Hamanoue S; Makimoto A
    Gan To Kagaku Ryoho; 2007 Feb; 34(2):175-80. PubMed ID: 17301523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Megatherapy and stem cell transplantation for Ewing's family of tumors: a critical review of current literature.
    Kalambakas SA; Moore TB; Feig SA
    Pediatr Transplant; 2004 Jun; 8 Suppl 5():83-8. PubMed ID: 15125709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tandem high-dose chemotherapy followed by autologous transplantation in patients with locally advanced or metastatic sarcoma.
    Lashkari A; Chow WA; Valdes F; Leong L; Phan V; Twardowski P; Kapoor N; Molina A; Al-Kadhimi Z; Frankel P; Somlo G
    Anticancer Res; 2009 Aug; 29(8):3281-8. PubMed ID: 19661346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment for Ewing's sarcoma family of tumors in children].
    Mugishima H; Chin M; Yokoyama R; Makimoto A
    Nihon Geka Gakkai Zasshi; 2005 Jul; 106(7):437-43. PubMed ID: 16045188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Favorable outcome of Ewing sarcoma family tumors to multiagent intensive preoperative chemotherapy: a single institution experience.
    Moschovi M; Trimis G; Stefanaki K; Anastasopoulos J; Syriopoulou V; Koultouki E; Tzortzatou-Stathopoulou F
    J Surg Oncol; 2005 Mar; 89(4):239-43. PubMed ID: 15726621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Megachemotherapy followed by autologous stem cell transplantation in children with Ewing's sarcoma.
    Drabko K; Zawitkowska-Klaczynska J; Wojcik B; Choma M; Zaucha-Prazmo A; Kowalczyk J; Gorczynska E; Toporski J; Kałwak K; Turkiewicz D; Chybicka A
    Pediatr Transplant; 2005 Oct; 9(5):618-21. PubMed ID: 16176419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interdisciplinary therapy of Ewing sarcoma].
    Jürgens H
    Praxis (Bern 1994); 1995 Sep; 84(37):1005-9. PubMed ID: 7481292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous stem cell transplantation for high-risk Ewing's sarcoma and other pediatric solid tumors.
    Fraser CJ; Weigel BJ; Perentesis JP; Dusenbery KE; DeFor TE; Baker KS; Verneris MR
    Bone Marrow Transplant; 2006 Jan; 37(2):175-81. PubMed ID: 16273111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors in non-metastatic Ewing's sarcoma tumor of bone: an analysis of 579 patients treated at a single institution with adjuvant or neoadjuvant chemotherapy between 1972 and 1998.
    Bacci G; Longhi A; Ferrari S; Mercuri M; Versari M; Bertoni F
    Acta Oncol; 2006; 45(4):469-75. PubMed ID: 16760184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.